{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:43:16Z","timestamp":1792204996392,"version":"4.4.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1910632"],"award-info":[{"award-number":["W81XWH1910632"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1F32DK105845"],"award-info":[{"award-number":["1F32DK105845"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0236000","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T16:07:39Z","timestamp":1601568459000},"page":"e0236000","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["REV-ERB agonism improves liver pathology in a mouse model of NASH"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-2518","authenticated-orcid":true,"given":"Kristine","family":"Griffett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Bedia-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4800-7976","authenticated-orcid":true,"given":"Bahaa","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Burris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"pone.0236000.ref001","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","author":"Y Fazel","year":"2016","journal-title":"Metabolism"},{"key":"pone.0236000.ref002","doi-asserted-by":"crossref","first-page":"154203","DOI":"10.1016\/j.metabol.2020.154203","article-title":"Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis","author":"SA Polyzos","year":"2020","journal-title":"Metabolism"},{"key":"pone.0236000.ref003","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2017.10.015","article-title":"Pharmacotherapy for NASH: Current and emerging","volume":"68","author":"MA Konerman","year":"2018","journal-title":"Journal of Hepatology"},{"key":"pone.0236000.ref004","article-title":"Nuclear receptors and non-alcoholic fatty liver disease: An update","author":"X Yang","year":"2020","journal-title":"Liver Research"},{"key":"pone.0236000.ref005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2017.05.011","article-title":"Targeting nuclear receptors for the treatment of fatty liver disease","volume":"179","author":"N Tanaka","year":"2017","journal-title":"Pharmacology & Therapeutics"},{"key":"pone.0236000.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/139875","article-title":"Nuclear Receptors in Nonalcoholic Fatty Liver Disease","volume":"2012","author":"JA L\u00f3pez-Vel\u00e1zquez","year":"2012","journal-title":"Journal of Lipids"},{"key":"pone.0236000.ref007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0092-8674(02)00825-5","article-title":"The Orphan Nuclear Receptor REV-ERB\u03b1 Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian Oscillator","volume":"110","author":"N Preitner","year":"2002","journal-title":"Cell"},{"key":"pone.0236000.ref008","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/hep.27049","article-title":"Novel role of nuclear receptor rev-erb\u03b1 in hepatic stellate cell activation: Potential therapeutic target for liver injury","volume":"59","author":"T Li","year":"2014","journal-title":"Hepatology"},{"key":"pone.0236000.ref009","doi-asserted-by":"crossref","first-page":"e0189330","DOI":"10.1371\/journal.pone.0189330","article-title":"Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism","volume":"12","author":"EN Stujanna","year":"2017","journal-title":"PLOS ONE"},{"key":"pone.0236000.ref010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/138161211795164211","article-title":"A Role for Rev-erb\u03b1 Ligands in the Regulation of Adipogenesis","volume":"17","author":"D.J. Kojetin","year":"2011","journal-title":"Current Pharmaceutical Design"},{"key":"pone.0236000.ref011","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1172\/JCI93910","article-title":"Circadian clock component REV-ERB\u03b1 controls homeostatic regulation of pulmonary inflammation","volume":"128","author":"M Pariollaud","year":"2018","journal-title":"Journal of Clinical Investigation"},{"key":"pone.0236000.ref012","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cb300541g","article-title":"A Liver-Selective LXR Inverse Agonist That Suppresses Hepatic Steatosis","volume":"8","author":"K Griffett","year":"2012","journal-title":"ACS Chemical Biology"},{"key":"pone.0236000.ref013","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2016.09.036","article-title":"Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease","volume":"479","author":"K Griffett","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"pone.0236000.ref014","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmet.2015.01.009","article-title":"The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis","volume":"4","author":"K Griffett","year":"2015","journal-title":"Molecular Metabolism"},{"key":"pone.0236000.ref015","doi-asserted-by":"crossref","first-page":"G762","DOI":"10.1152\/ajpgi.00476.2011","article-title":"Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice","author":"JL Trevaskis","year":"2012","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"pone.0236000.ref016","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbrc.2015.03.070","article-title":"Suppression of atherosclerosis by synthetic REV-ERB agonist","volume":"460","author":"S Sitaula","year":"2015","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"pone.0236000.ref017","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/acsptsci.8b00003","article-title":"Inhibition of Hepatotoxicity by a LXR Inverse Agonist in a Model of Alcoholic Liver Disease","volume":"1","author":"M Sengupta","year":"2018","journal-title":"ACS Pharmacology & Translational Science"},{"key":"pone.0236000.ref018","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature11030","article-title":"Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists","volume":"485","author":"LA Solt","year":"2012","journal-title":"Nature"},{"key":"pone.0236000.ref019","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2017.12.019","article-title":"Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice","volume":"154","author":"B Pourcet","year":"2018","journal-title":"Gastroenterology"},{"key":"pone.0236000.ref020","doi-asserted-by":"crossref","first-page":"2S28","DOI":"10.1016\/S1262-3636(17)30070-8","article-title":"GLP-1 receptor agonists in NAFLD","volume":"43","author":"J-M Petit","year":"2017","journal-title":"Diabetes & Metabolism"},{"key":"pone.0236000.ref021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000447276","article-title":"Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis","volume":"34","author":"E Scorletti","year":"2016","journal-title":"Digestive Diseases"},{"key":"pone.0236000.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dme.12377_1","article-title":"2 diabetes and NAFLD","volume":"31","author":"Type Obesity","year":"2014","journal-title":"Diabetic Medicine"},{"key":"pone.0236000.ref023","doi-asserted-by":"crossref","DOI":"10.1186\/s40842-016-0027-7","article-title":"Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus","volume":"2","author":"P Portillo-Sanchez","year":"2016","journal-title":"Clinical Diabetes and Endocrinology"},{"key":"pone.0236000.ref024","article-title":"Novel predictors of diabetes\u2014NAFLD, diabetes and CVD","author":"E. Bonora","year":"2017","journal-title":"Endocrine Abstracts"},{"key":"pone.0236000.ref025","doi-asserted-by":"crossref","first-page":"144549","DOI":"10.1016\/j.gene.2020.144549","article-title":"Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","author":"G Feng","year":"2020","journal-title":"Gene"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T16:07:53Z","timestamp":1601568473000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236000"}},"subtitle":[],"editor":[{"given":"Michele","family":"Vacca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0236000","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.29.177378","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}